Neurological Devices Market Size, Share & COVID-19 Analysis | Europe | 2023-2029 | MedSuite | Includes: Ultrasonic Aspirator Market, Neurovascular Guidewires Market, and 12 more
- Year: 2023
- Scope: 10 Years
- Region: Europe
- Pages: 692
- Published Date: 11/21/2022
- Type: MedSuite
Overall, the European Neurological Device market was valued at approximately €1.3 billion in 2022. This is expected to increase over the forecast period at a CAGR of 4.2% to reach approximately €1.8 billion.
The full report suite on the European market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, balloon occlusion devices, neurovascular thrombectomy devices, ultrasonic aspirators, neuromodulation devices, intrathecal pumps, stereotactic devices and transcranial magnetic simulators.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
In 2022, approximately 190,000 neurological device procedures were conducted across Europe. This analysis will include procedures associated with cerebrospinal fluid (CSF) shunting, liquid embolization of AVM, interventional aneurysm treatments, aspiration thrombectomy, neuromodulation device and intrathecal pump implantation, and ultrasonic aspiration.
EUROPEAN NEUROLOGICAL DEVICE MARKET TRENDS
Changes in reimbursement policies in Europe are limiting the growth of the neurological device market. Policies in the Benelux region limit the number of neuromodulation devices reimbursed in a given year, cutting down on unit sales for spinal cord stimulation and pulling down the average selling prices of deep brain stimulation devices.
EUROPEAN NEUROLOGICAL DEVICE MARKET SHARE INSIGHTS
Overall, within the European neurological device market there are three dominant competitors: Medtronic, Stryker, and Boston Scientific.
Medtronic has maintained its leading position in the neurological device market, but competitors have broken its monopolies in several markets and taken notable shares.
EUROPEAN NEUROLOGICAL DEVICE MARKET SEGMENTATION SUMMARY
- Cerebrospinal Fluid (CSF) Management Market – Includes:
- CSF Shunts, CSF Drainage Systems
- Detachable Coils Market – Includes:
- Bare Platinum, Coated
- Liquid Embolic Market
- Neurovascular Guidewire Market
- Neurovascular Catheter Market – Includes:
- Over-the-Wire Microcatheter, Flow-Directed Microcatheter, and Guide Catheters
- Neurovascular Stent Market – Includes:
- Traditional, Flow Diversion, and Intrasaccular Devices
- Aneurysm Clip Market – Includes:
- Titanium, Cobalt Chromium
- Balloon Occulsion Market
- Neurovascular Thrombectomy Market – Includes:
- Stent Retrievers, Aspiration Catheters
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
-
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| European Neurological Device Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Procedure Numbers |
| Markets Included |
| Key Report Updates |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE European Neurological Device Market |
| 2.1 Introduction |
| 2.2 Country Profile |
| 2.3 Analysis By Market Segment |
| 2.3.1 Worst Case Scenario |
| 2.3.2 Base Case Scenario |
| 2.3.3 Best Case Scenario |
| Disease Overview |
| 3.1 Basic Anatomy |
| 3.2 Disease Pathology and Disorders |
| 3.2.1 Introduction |
| 3.2.2 General Diagnostics and Neurosurgery |
| 3.2.3 Tumor and Brain Cancer |
| 3.2.4 Brain Arteriovenous Malformations |
| 3.2.5 Ischemic Stroke |
| 3.2.6 Brain Aneurysm |
| 3.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure |
| 3.2.7.1 Hydrocephalus and Intracranial Pressure Disorder |
| 3.2.7.2 Cerebral Edema |
| 3.2.8 Indication for Neuromodulation |
| 3.2.9 Traumatic Brain injury |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Product Portfolios |
| 4.2.1 Cerebrospinal Fluid Management |
| 4.2.2 Detachable Coils |
| 4.2.3 Liquid Embolics |
| 4.2.4 Neurovascular Catheters |
| 4.2.5 Neurovascular Guidewires |
| 4.2.6 Neurovascular Stents |
| 4.2.7 Balloon Occlusion Devices |
| 4.2.8 Aneurysm Clip |
| 4.2.9 Neurovascular Thrombus Management |
| 4.2.10 Neuromodulation Devices |
| 4.2.10.1 Introduction |
| 4.2.10.2 Spinal Cord Stimulators |
| 4.2.10.3 Vagus Nerve Stimulators |
| 4.2.10.4 Deep Brain Stimulators |
| 4.2.10.5 Gastric Electric Stimulators |
| 4.2.10.6 Sacral Nerve Stimulators |
| 4.2.10.7 Dorsal Root Ganglion Stimulation Market |
| 4.2.10.8 Responsive Neurostimulation Market |
| 4.2.11 Intrathecal Pumps |
| 4.2.12 Stereotactic Devices |
| 4.2.13 Neuroendoscopy Devices |
| 4.2.14 Ultrasonic Aspiration Devices |
| 4.3 Regulatory Issues and Recalls |
| 4.3.1 Cerebrospinal Fluid Management |
| 4.3.2 Detachable Coils |
| 4.3.3 Neurovascular Catheters |
| 4.3.4 Neurovascular Stent |
| 4.3.5 Balloon Occlusion Devices |
| 4.3.6 Neuromodulation Devices |
| 4.3.7 Neuroendoscopy |
| 4.3.9 Stereotactic Devices |
| 4.3.10 Ultrasonic Aspiration |
| 4.3.11 Neurological Microscopes |
| 4.3.12 Intrathecal Pumps |
| 4.3.13 Mechanical Thrombectomy |
| 4.4 Clinical Trials |
| 4.4.1 Cerebrospinal Fluid Management |
| 4.4.2 Detachable Coils |
| 4.4.3 Liquid Embolics |
| 4.4.4 Neurovascular Catheters |
| 4.4.5 Neurovascular Guidewires |
| 4.4.6 Neurovascular Stent |
| 4.4.7 Neuromodulation devices |
| 4.4.8 Neuroendoscopy |
| 4.4.9 Stereotactic Devices |
| 4.4.10 Ultrasonic Aspiration |
| 4.4.11 Aneurysm Clip |
| 4.4.12 Neurological Microscopes |
| 4.4.13 Mechanical Thrombectomy |
| European Neurological Device Market Overview |
| 5.1 Introduction |
| 5.1.1 Cerebrospinal Fluid Management |
| 5.1.2 Interventional Neuroradiology |
| 5.1.3 Neuromodulation |
| 5.1.4 Neurosurgery |
| 5.1.5 Neurovascular Thrombectomy |
| 5.1.6 Transcranial Magnetic Stimulators |
| 5.2 Currency Exchange Rate |
| 5.3 Market Overview & Trend Analysis |
| 5.4 Drivers and Limiters |
| 5.4.1 Market Drivers |
| 5.4.1.1 Cerebrospinal Fluid Management |
| 5.4.1.2 Interventional Neuroradiology |
| 5.4.1.3 Neuromodulation |
| 5.4.1.4 Neurosurgery |
| 5.4.1.5 Neurovascular Thrombectomy |
| 5.4.1.6 Transcranial Magnetic Stimulator |
| 5.4.2 Market Limiters |
| 5.4.2.1 Cerebrospinal Fluid Management |
| 5.4.2.2 Interventional Neuroradiology |
| 5.4.2.3 Neuromodulation |
| 5.4.2.4 Neurosurgery |
| 5.4.2.5 Neurovascular Thrombectomy |
| 5.4.2.6 Transcranial Magnetic Stimulator |
| 5.5 Competitive Market Share Analysis |
| 5.6 Mergers and Acquisitions |
| 5.7 Company Profiles |
| 5.8 SWOT Analysis |
| Country Profiles |
| 6.1 Introduction |
| 6.1.1 Population |
| 6.1.2 GDP Per Capita |
| 6.1.3 Price Index |
| 6.2 Germany |
| 6.3 France |
| 6.4 United Kingdom |
| 6.5 Italy |
| 6.6 Spain |
| 6.7 Benelux |
| 6.8 Scandinavia |
| 6.9 Austria |
| 6.10 Switzerland |
| 6.11 Portugal |
| Procedure Numbers |
| 7.1 Procedures |
| 7.1.1 Cerebrospinal Fluid Shunting Procedures |
| 7.1.1.1 Shunt Implantation Procedures |
| 7.1.1.2 Shunt Replacement Procedures |
| 7.1.2 Liquid Embolization of AVM Procedures |
| 7.1.3 Interventional Aneurysm Treatment Procedures |
| 7.1.3.1 Detachable Coil Embolization Procedures |
| 7.1.3.2 Traditional Neurovascular Stent Procedures |
| 7.1.3.3 Flow Diverting Stent Procedures |
| 7.1.3.4 Intrasaccular Stent Procedures |
| 7.1.3.5 Aneurysm Clipping Procedures |
| 7.1.4 Aspiration Thrombectomy Procedures |
| 7.1.5 Neuromodulation Device Implantation Procedures |
| 7.1.5.1 Spinal Cord Stimulator Implantation Procedures |
| 7.1.5.2 Deep Brain Stimulator Implantation Procedures |
| 7.1.5.3 Sacral Nerve Stimulator Implantation Procedures |
| 7.1.5.4 Vagus Nerve Stimulator Implantation Procedures |
| 7.1.5.5 Gastric Electric Stimulator Implantation Procedures |
| 7.1.6 Intrathecal Pump Implantation Procedures |
| 7.1.7 Ultrasonic Aspiration Procedures |
| Cerebrospinal Fluid Management Market |
| 8.1 Introduction |
| 8.2 Market Overview |
| 8.3 Market Analysis and Forecast |
| 8.3.1 Cerebrospinal Fluid Shunt Market |
| 8.3.1.1 Adjustable Pressure Cerebrospinal Fluid Shunt Market |
| 8.3.1.2 Fixed Pressure Cerebrospinal Fluid Shunt Market |
| 8.3.2 Cerebrospinal Fluid External Drainage System Market |
| 8.3.2.1 Ventricular Drainage System Market |
| 8.3.2.2 Lumbar Drainage System Market |
| 8.4 Drivers and Limiters |
| 8.4.1 Market Drivers |
| 8.4.2 Market Limiters |
| 8.5 Competitive Market Share Analysis |
| Detachable Coil Market |
| 9.1 Introduction |
| 9.2 Market Overview |
| 9.3 Market Analysis and Forecast |
| 9.3.1 Total Detachable Coil Market |
| 9.3.2 Bare Platinum Detachable Coil Market |
| 9.3.3 Coated Detachable Coil Market |
| 9.4 Drivers and Limiters |
| 9.4.1 Market Drivers |
| 9.4.2 Market Limiters |
| 9.5 Competitive Market Share Analysis |
| Liquid Embolic Market |
| 10.1 Introduction |
| 10.2 Market Analysis and Forecast |
| 10.3 Drivers and Limiters |
| 10.3.1 Market Drivers |
| 10.3.2 Market Limiters |
| 10.4 Competitive Market Share Analysis |
| Neurovascular Guidewire Market |
| 11.1 Introduction |
| 11.2 Market Analysis and Forecast |
| 11.3 Drivers and Limiters |
| 11.3.1 Market Drivers |
| 11.3.2 Market Limiters |
| 11.4 Competitive Market Share Analysis |
| Neurovascular Catheter Market |
| 12.1 Introduction |
| 12.2 Market Overview |
| 12.3 Market Analysis and Forecast |
| 12.3.1 Over-the-Wire Microcatheter Market |
| 12.3.2 Flow-Directed Microcatheter Market |
| 12.3.3 Neurovascular Guiding Catheter Market |
| 12.3.3.1 Standard Guiding Catheter Market |
| 12.3.3.2 Balloon Guiding Catheter Market |
| 12.4 Drivers and Limiters |
| 12.4.1 Market Drivers |
| 12.4.2 Market Limiters |
| 12.5 Competitive Market Share Analysis |
| Neurovascular Stent Market |
| 13.1 Introduction |
| 13.2 Market Overview |
| 13.3 Market Analysis and Forecast |
| 13.3.1 Traditional Neurovascular Stent Market |
| 13.3.1.1 Laser Cut Neurovascular Stent Market |
| 13.3.1.2 Braided Neurovascular Stent Market |
| 13.3.2 Flow Diversion Stent Market |
| 13.3.3 Intrasaccular Stent Market |
| 13.4 Drivers and Limiters |
| 13.4.1 Market Drivers |
| 13.4.2 Market Limiters |
| 13.5 Competitive Market Share Analysis |
| Aneurysm Clip Market |
| 14.1 Introduction |
| 14.2 Market Overview |
| 14.3 Market Analysis and Forecast |
| 14.3.1 Total Aneurysm Clip Market |
| 14.3.2 Aneurysm Clip Market by Material |
| 14.3.2.1 Titanium Aneurysm Clip Market |
| 14.3.2.2 Cobalt Chromium Aneurysm Clip Market |
| 14.4 Drivers and Limiters |
| 14.4.1 Market Drivers |
| 14.4.2 Market Limiters |
| 14.5 Competitive Market Share Analysis |
| Balloon Occlusion Device Market |
| 15.1 Introduction |
| 15.2 Market Analysis and Forecast |
| 15.3 Drivers and Limiters |
| 15.3.1 Market Drivers |
| 15.3.2 Market Limiters |
| 15.4 Competitive Market Share Analysis |
| Neurovascular Thrombectomy Market |
| 16.1 Introduction |
| 16.2 Market Overview |
| 16.3 Market Analysis and Forecast |
| 16.3.1 Stent Retriever Market |
| 16.3.2 Aspiration Catheter Market |
| 16.4 Drivers and Limiters |
| 16.4.1 Market Drivers |
| 16.4.2 Market Limiters |
| 16.5 Competitive Market Share Analysis |
| Ultrasonic Aspirator Market |
| 17.1 Introduction |
| 17.2 Market Overview |
| 17.3 Market Analysis and Forecast |
| 17.3.1 Ultrasonic Aspirator Generator Market |
| 17.3.2 Ultrasonic Aspirator Disposable Probe Tip Market |
| 17.3.3 Ultrasonic Aspirator Disposable Tubing Market |
| 17.4 Drivers and Limiters |
| 17.4.1 Market Drivers |
| 17.4.2 Market Limiters |
| 17.5 Competitive Market Share Analysis |
| Neuromodulation Device Market |
| 18.1 Introduction |
| 18.1.1 Spinal Cord Stimulators |
| 18.1.2 Deep Brain Stimulators |
| 18.1.3 Sacral Nerve Stimulators |
| 18.1.4 Vagus Nerve Stimulators |
| 18.1.5 Gastric Electric Stimulators |
| 18.2 Market Overview |
| 18.3 Market Analysis and Forecast |
| 18.3.1 Spinal Cord Stimulator Market |
| 18.3.1.1 Spinal Cord Stimulator Generator Market |
| 18.3.1.2 Spinal Cord Stimulator Market by Battery Type |
| 18.3.1.2.1 Rechargeable Spinal Cord Stimulator Generator Market |
| 18.3.1.2.2 Non-Rechargeable Spinal Cord Stimulator Generator Market |
| 18.3.1.3 Spinal Cord Stimulator Market by Channel Type |
| 18.3.1.3.1 Single-Channel Spinal Cord Stimulator Generator Market |
| 18.3.1.3.2 Multi-Channel Spinal Cord Stimulator Generator Market |
| 18.3.1.4 Spinal Cord Stimulator Lead Market |
| 18.3.2 Deep Brain Stimulator Market |
| 18.3.3 Sacral Nerve Stimulator Market |
| 18.3.3.1 Sacral Nerve Stimulator Market |
| 18.3.3.2 Sacral Nerve Stimulator Market by Battery Type |
| 18.3.3.2.1 Rechargeable Sacral Nerve Stimulator Market |
| 18.3.3.2.2 Non-Rechargeable Sacral Nerve Stimulator Market |
| 18.3.4 Vagus Nerve Stimulator Market |
| 18.3.5 Gastric Electric Stimulator Market |
| 18.4 Drivers and Limiters |
| 18.4.1 Spinal Cord Stimulation Market |
| 18.4.1.1 Market Drivers |
| 18.4.1.2 Market Limiters |
| 18.4.2 Deep Brain Stimulation Market |
| 18.4.2.1 Market Drivers |
| 18.4.2.2 Market Limiters |
| 18.4.3 Sacral Nerve Stimulation Market |
| 18.4.3.1 Market Drivers |
| 18.4.3.2 Market Limiters |
| 18.4.4 Vagus Nerve Stimulation Market |
| 18.4.4.1 Market Drivers |
| 18.4.4.2 Market Limiters |
| 18.4.5 Gastric Electric Stimulation Market |
| 18.4.5.1 Market Drivers |
| 18.4.5.2 Market Limiters |
| 18.5 Competitive Market Share Analysis |
| Intrathecal Pump Market |
| 19.1 Introduction |
| 19.2 Market Analysis and Forecast |
| 19.3 Drivers and Limiters |
| 19.3.1 Market Drivers |
| 19.3.2 Market Limiters |
| 19.4 Competitive Market Share Analysis |
| Stereotactic Device Market |
| 20.1 Introduction |
| 20.2 Market Overview |
| 20.3 Market Analysis and Forecast |
| 20.3.1 Frame-Based Stereotactic Device Market |
| 20.3.2 Frameless Stereotactic Device Market |
| 20.4 Drivers and Limiters |
| 20.4.1 Market Drivers |
| 20.4.2 Market Limiters |
| 20.5 Competitive Market Share Analysis |
| Transcranial Magnetic Stimulator Market |
| 21.1 Introduction |
| 21.2 Market Analysis and Forecast |
| 21.3 Drivers and Limiters |
| 21.3.1 Market Drivers |
| 21.3.2 Market Limiters |
| 21.4 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| Adeor Medical | MHT |
| Aesculap | MicroPort |
| ANT Neuro | MicroVention |
| Asahi Intecc | Misonix |
| Axonics | MIVI Neuroscience |
| Balt | Mizuho |
| Bioventus | MRC Systems |
| Boston Scientific | Neuromedex |
| Brainlab | Neuronetics |
| BrainsWay | NeuroPace |
| BTG | Neurosoft |
| Cerenovus | Nevro |
| Cerus Endovascular | Nexstim |
| Cirtec | Penumbra |
| Cordis | Peter Lazic |
| Dewimed | Phenox |
| Deymed Diagnostic | Rapid Medical |
| Dispomedica | Reshape Lifesciences |
| Elekta | SAI Infusion Technologies |
| Embolx | Scientia Vascular |
| FHC | Sophysa |
| Flowonix | Soring |
| Inomed | Spiegelberg |
| Insera Therapeutics | Stimwave |
| Integra LifeSciences | Stryker |
| IntraPace | Teleflex |
| Kaneka | Tokai Medical Products |
| LivaNova | Tricumed |
| MAG & More | Varian |
| Magstim |
List of Charts
| Chart 1‑1: Neurological Device Market by Segment, Europe, 2022 – 2029 |
| Chart 1‑2: Neurological Device Market Overview, Europe, 2022 & 2029 |
| Chart 2‑1: Multi-Scenario Neurological Device Market Forecast, Europe, 2019 – 2029 (€M) |
| Chart 5‑1: Neurological Device Market by Segment, Europe, 2019 – 2029 |
| Chart 5‑2: Leading Competitors, Neurological Device Market, Europe, 2022 |
| Chart 6‑1: Country Profile, Germany, 2022 |
| Chart 6‑2: Country Profile, France, 2022 |
| Chart 6‑3: Country Profile, United Kingdom, 2022 |
| Chart 6‑4: Country Profile, Italy, 2022 |
| Chart 6‑5: Country Profile, Spain, 2022 |
| Chart 6‑6: Country Profile, Benelux, 2022 |
| Chart 6‑7: Country Profile, Scandinavia, 2022 |
| Chart 6‑8: Country Profile, Austria, 2022 |
| Chart 6‑9: Country Profile, Switzerland, 2022 |
| Chart 6‑10: Country Profile, Portugal, 2022 |
| Chart 7‑1: Neurological Procedures by Segment, Europe, 2019 – 2029 |
| Chart 8‑1: Cerebrospinal Fluid Management Market by Segment, Europe, 2019 – 2029 |
| Chart 8‑2: Leading Competitors, Cerebrospinal Fluid Management Market, Europe, 2022 |
| Chart 8‑3: Leading Competitors, Cerebrospinal Fluid Shunt Market, Europe, 2022 |
| Chart 9‑1: Detachable Coil Market by Segment, Europe, 2019 – 2029 |
| Chart 9‑2: Leading Competitors, Detachable Coil Market, Europe, 2022 |
| Chart 10‑1: Liquid Embolic Market, Europe, 2019 – 2029 |
| Chart 10‑2: Leading Competitors, Liquid Embolic Market, Europe, 2022 |
| Chart 11‑1: Neurovascular Guidewire Market, Europe, 2019 – 2029 |
| Chart 11‑2: Leading Competitors, Neurovascular Guidewire Market, Europe, 2022 |
| Chart 12‑1: Neurovascular Catheter Market by Segment, Europe, 2019 – 2029 |
| Chart 12‑2: Leading Competitors, Neurovascular Catheter Market, Europe, 2022 |
| Chart 13‑1: Neurovascular Stent Market by Segment, Europe, 2019 – 2029 |
| Chart 13‑2: Leading Competitors, Neurovascular Stent Market, Europe, 2022 |
| Chart 14‑1: Aneurysm Clip Market by Material, Europe, 2019 – 2029 |
| Chart 14‑2: Leading Competitors, Aneurysm Clip Market, Europe, 2022 |
| Chart 15‑1: Balloon Occlusion Device Market, Europe, 2019 – 2029 |
| Chart 15‑2: Leading Competitors, Balloon Occlusion Device Market, Europe, 2022 |
| Chart 16‑1: Neurovascular Thrombectomy Market by Segment, Europe, 2019 – 2029 |
| Chart 16‑2: Leading Competitors, Neurovascular Thrombectomy Market, Europe, 2022 |
| Chart 17‑1: Ultrasonic Aspirator Market by Segment, Europe, 2019 – 2029 |
| Chart 17‑2: Leading Competitors, Ultrasonic Aspirator Market, Europe, 2022 |
| Chart 18‑1: Neuromodulation Device Market by Segment, Europe, 2019 – 2029 |
| Chart 18‑2: Leading Competitors, Neuromodulation Device Market, Europe, 2022 |
| Chart 19‑1: Intrathecal Pump Market, Europe, 2019 – 2029 |
| Chart 19‑2: Leading Competitors, Intrathecal Pump Market, Europe, 2022 |
| Chart 20‑1: Stereotactic Device Market by Segment, Europe, 2019 – 2029 |
| Chart 20‑2: Leading Competitors, Stereotactic Device Market, Europe, 2022 |
| Chart 21‑1: Transcranial Magnetic Stimulator Market, Europe, 2019 – 2029 |
| Chart 21‑2: Leading Competitors, Transcranial Magnetic Stimulator Market, Europe, 2022 |
List of Figures
| Figure 1‑1: Neurological Device Market Share Ranking by Segment, Europe, 2022 (1 of 3) |
| Figure 1‑2: Neurological Device Market Share Ranking by Segment, Europe, 2022 (2 of 3) |
| Figure 1‑3: Neurological Device Market Share Ranking by Segment, Europe, 2022 (3 of 3) |
| Figure 1‑4: Companies Researched in this Report |
| Figure 1‑5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) |
| Figure 1‑6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) |
| Figure 1‑7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) |
| Figure 1‑8: Recent Events in the Neurological Device Market, Europe, 2019 – 2022 (1 of 2) |
| Figure 1‑8: Recent Events in the Neurological Device Market, Europe, 2019 – 2022 (2 of 2) |
| Figure 1‑9: Neurological Device Procedures Covered, Europe |
| Figure 1‑10: Neurological Device Markets Covered, Europe (1 of 2) |
| Figure 1‑10: Neurological Device Markets Covered, Europe (2 of 2) |
| Figure 1‑11: Key Report Updates |
| Figure 1‑12: Version History |
| Figure 2‑1: Neurological Device Market by Segment, Worst Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) |
| Figure 2‑2: Neurological Device Market by Segment, Worst Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) |
| Figure 2‑3: Neurological Device Market by Segment, Base Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) |
| Figure 2‑4: Neurological Device Market by Segment, Base Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) |
| Figure 2‑5: Neurological Device Market by Segment, Best Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) |
| Figure 2‑6: Neurological Device Market by Segment, Best Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) |
| Figure 3‑1: Neurology Disease Overview |
| Figure 4‑1: Shunt Types |
| Figure 4‑2: Cerebrospinal Fluid Management by Company |
| Figure 4‑3: Detachable Coils by Company |
| Figure 4‑4: Liquid Embolics by Company |
| Figure 4‑5: Neurovascular Catheters by Company |
| Figure 4‑6: Neurovascular Guidewires by Company |
| Figure 4‑7: Neurovascular Stent by Company |
| Figure 4‑8: Balloon Occlusion Devices by Company |
| Figure 4‑9: Aneurysm Clip Devices by Company |
| Figure 4‑10: Neurovascular Thrombus Management Devices by Company |
| Figure 4‑11: Neuromodulation Devices by Company |
| Figure 4‑12: Intrathecal Pumps Devices by Company |
| Figure 4‑13: Stereotactic Devices by Company |
| Figure 4‑14: Neuroendoscopy by Company |
| Figure 4‑15: Ultrasonic Aspiration Devices by Company |
| Figure 4‑16: Class 2 Device Recall Natus EDS3 CSF External Drainage System |
| Figure 4‑17: Class 2 Device Recall Medtronic PS Medical CSFFlow Control Valves |
| Figure 4‑18: Class 2 Device Recall MicroVention Terumo Microplex 10, Helical 10 Soft |
| Figure 4‑19: Class 2 Device Recall MicroVention Terumo HydroFrame 10 and 18 |
| Figure 4‑20: Class 2 Device Recall MicroVention Terumo Microplex 10, Compass 10 |
| Figure 4‑21: Class 2 Device Recall MicroVention Terumo HydroSoft 10, HydroSoft 3D |
| Figure 4‑22: Class 2 Device Recall GALAXY G3 Mini Microcoil Delivery System |
| Figure 4‑23: Class 2 Device Recall C315HIS Delivery Catheter |
| Figure 4‑24: Class 2 Device Recall MIVI Super 90 Guide Catheters |
| Figure 4‑25:Class 2 Device Recall MAMBA Flex 135 Microcatheter |
| Figure 4‑26: Class 2 Device Recall Intracranial Neurovascular Stent |
| Figure 4‑27: Class 2 Device Recall MIVI Super 90 Guide Catheters |
| Figure 4‑28: Class 2 Device Recall MAMBA Flex 135 Microcatheter |
| Figure 4‑29:Class 2 Device Recall 6F Launcher Guide Catheter |
| Figure 4‑30: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter |
| Figure 4‑31:Class 2 Device Recall Merci Balloon Guide Catheters |
| Figure 4‑32: Class 2 Device Recall Medtronic Wireless Recharger |
| Figure 4‑33: Class 2 Device Recall Model B352000 Percept PC BrainSense Implantable Neurostimulator |
| Figure 4‑34: Class 2 Device Recall A610 |
| Figure 4‑35: Class 2 Device Recall Percept PC Implantable Neurostimulator (INS) |
| Figure 4‑36: Class 2 Device Recall KARL STORZ NEUROFIBERSCOPE |
| Figure 4‑37: Class 2 Device Recall Karl Storz NeuroFiberscope |
| Figure 4‑38: Class 2 Device Recall FLEXIBLE NEURO FIBERSCOPE |
| Figure 4‑39: Class 2 Device Recall Stealth Autoguide Tracker, Model: 28248 |
| Figure 4‑40:Class 2 Device Recall Medtronic |
| Figure 4‑41: Class 2 Device Recall Polaris Spectra Camera for StealthStation S7 System |
| Figure 4‑42:Class 2 Device Recall Leksell Vantage Stereotactic System |
| Figure 4‑43: Class 2 Device Recall Leksell Vantage Stereotactic System |
| Figure 4‑44:Class 2 Device Recall ROSA Brain 3.0 Application Brain and ROSA One 3.1 |
| Figure 4‑45: Class 2 Device Recall Trident Endoscopic Ultrasonic Aspiration Needle (FNA) |
| Figure 4‑46: Class 2 Device Recall Footswitch accessory |
| Figure 4‑47: Class 2 Device Recall Leica M220 F12 |
| Figure 4‑48: Class 2 Device Recall Prometra Programmable Pump System |
| Figure 4‑49: Class 2 Device Recall Medtronic Synchromed II Implantable Drug Infusion Pump |
| Figure 4‑50: Class 2 Device Recall AXS Vecta 71 , Vecta 74 Aspiration Catheter |
| Figure 4‑51: Class 1 Device Recall MINDFRAME CAPTURE(TM) LP Revascularization Device |
| Figure 4‑52: Class 2 Device Recall Trevo XP ProVue System |
| Figure 4‑53: The Effect of Lumbar CSF Drainage on the Neurologic Outcome Improvement in OHCA Underwent TTM |
| Figure 4‑54: Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial (OPEN-UP) |
| Figure 4‑55: Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension. (HYDROPTIC) |
| Figure 4‑56: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil |
| Figure 4‑57: Prospective, Randomized, Controlled, Open Label, All China, Multi-Center, Registration Trial of the MICROPORT NEUROTECH Coil Embolization System for the Traetment of Intracranial Aneurysms |
| Figure 4‑58: Transcatheter Leak Closure with Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures (TREASURE) |
| Figure 4‑59: Middle Meningeal Artery Embolization with Liquid Embolic Agent for Treatment of Chronic Subdural Hematoma |
| Figure 4‑60: Treatment of Cerebral Arteriovenous Malformations with SQUID Liquid Embolic Agent - The CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study |
| Figure 4‑61: quid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding Syndrome (SQUIDperi Study) (SQUIDperi) |
| Figure 4‑62: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations |
| Figure 4‑63: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil |
| Figure 4‑64: Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion |
| Figure 4‑65: Inflammatory and Infectious Diseases of the Nervous System |
| Figure 4‑66: Safety and Utility Profile of the Asahi Chikai Black 18 neurovascular guidewire in Large Vessel Occlusive Stroke: SURE 18 Registry |
| Figure 4‑67: Evaluation of Safety and Performance of the Neuroform AtlasTM Stent System for Intracranial Aneurysm Treatment - Post Market Clinical Follow-up |
| Figure 4‑68: Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System |
| Figure 4‑69: MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization (PARADIGM-EXT) |
| Figure 4‑70: The Motor Network in Essential Tremor: Mechanisms of Therapy |
| Figure 4‑71: Wearable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease (WAVE-AD) |
| Figure 4‑72: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents Visiting the Emergency Department |
| Figure 4‑73: Minimally-invasive Surgery Versus Craniotomy in Patients with Supratentorial Hypertensive Intracerebral Hemorrhage: A Multi-center Randomized Controlled Trial |
| Figure 4‑74: Minimally Invasive Treatment of Hypertensive Basal Ganglia Hemorrhage by Transfrontal Keyhole Neuroendoscopy |
| Figure 4‑75: Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases |
| Figure 4‑76: Cyberknife Radiosurgery for Patients with Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity |
| Figure 4‑77: Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy (FSRT) in Unresected Brain Metastases |
| Figure 4‑78: Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke (SESAME) |
| Figure 4‑79: Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Stroke Patients (RapidPulseFS) |
| Figure 4‑80: A Single-Arm Objective Performance Criteria Trail For Intracranial Thrombus Aspiration Catheter |
| Figure 4‑81: A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping |
| Figure 4‑82: Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends |
| Figure 4‑83: Regional Strategy for Transfer for Mechanical Thrombectomy (START) |
| Figure 4‑84: Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion (DISCOUNT) |
| Figure 5‑1: Currency Exchange Rate, 2022 |
| Figure 5‑2: Neurological Device Market by Segment, Europe, 2019 – 2029 (€M) (1 of 2) |
| Figure 5‑3: Neurological Device Market by Segment, Europe, 2019 – 2029 (€M) (2 of 2) |
| Figure 5‑4: Neurological Device Market by Segment, Europe, 2019 – 2029 (US$M) (1 of 2) |
| Figure 5‑5: Neurological Device Market by Segment, Europe, 2019 – 2029 (US$M) (2 of 2) |
| Figure 5‑6: Leading Competitors, Neurological Device Market, Europe, 2022 (1 of 3) |
| Figure 5‑7: Leading Competitors, Neurological Device Market, Europe, 2022 (2 of 3) |
| Figure 5‑8: Leading Competitors, Neurological Device Market, Europe, 2022 (3 of 3) |
| Figure 7‑1: Neurological Procedures by Segment, Europe, 2019 – 2029 |
| Figure 7‑2: Cerebrospinal Fluid Shunting Procedures by Type, Europe, 2019 – 2029 |
| Figure 7‑3: Cerebrospinal Fluid Shunting Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑4: Shunt Implantation Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑5: Shunt Replacement Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑6: Liquid Embolization of AVM Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑7: Interventional Aneurysm Treatment Procedures by Modality, Europe, 2019 – 2029 |
| Figure 7‑8: Detachable Coil Embolization Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑9: Traditional Neurovascular Stent Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑10: Flow Diverting Stent Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑11: Intrasaccular Stent Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑12: Aneurysm Clipping Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑13: Aspiration Thrombectomy Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑14: Neuromodulation Device Implantation Procedures by Segment, Europe, 2019 – 2029 |
| Figure 7‑15: Spinal Cord Stimulator Implantation Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑17: Deep Brain Stimulator Implantation Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑19: Sacral Nerve Stimulator Implantation Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑16: Vagus Nerve Stimulator Implantation Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑18: Gastric Electric Stimulator Implantation Procedures, Europe, 2019 – 2029 |
| Figure 7‑20: Intrathecal Pump Implantation Procedures by Country, Europe, 2019 – 2029 |
| Figure 7‑21: Ultrasonic Aspiration Procedures by Country, Europe, 2019 – 2029 |
| Figure 8‑1: Cerebrospinal Fluid Management Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 8‑2: Cerebrospinal Fluid Management Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 8‑3: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 8‑4: Cerebrospinal Fluid Shunt Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 8‑5: Total Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 |
| Figure 8‑6: Units Sold by Country, Total Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 |
| Figure 8‑7: Average Selling Price by Country, Total Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (€) |
| Figure 8‑8: Average Selling Price by Country, Total Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (US$) |
| Figure 8‑9: Market Value by Country, Total Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (€M) |
| Figure 8‑10: Market Value by Country, Total Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (US$M) |
| Figure 8‑11: Adjustable Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 |
| Figure 8‑12: Units Sold by Country, Adjustable Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 |
| Figure 8‑13: Average Selling Price by Country, Adjustable Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (€) |
| Figure 8‑14: Average Selling Price by Country, Adjustable Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (US$) |
| Figure 8‑15: Market Value by Country, Adjustable Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (€M) |
| Figure 8‑16: Market Value by Country, Adjustable Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (US$M) |
| Figure 8‑17: Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 |
| Figure 8‑18: Units Sold by Country, Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 |
| Figure 8‑19: Average Selling Price by Country, Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (€) |
| Figure 8‑20: Average Selling Price by Country, Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (US$) |
| Figure 8‑21: Market Value by Country, Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (€M) |
| Figure 8‑22: Market Value by Country, Fixed Pressure Cerebrospinal Fluid Shunt Market, Europe, 2019 – 2029 (US$M) |
| Figure 8‑23: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 8‑24: Cerebrospinal Fluid External Drainage System Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 8‑25: Total Cerebrospinal Fluid External Drainage System Market, Europe, 2019 – 2029 |
| Figure 8‑26: Units Sold by Country, Total Cerebrospinal Fluid External Drainage System Market, Europe, 2019 – 2029 |
| Figure 8‑27: Average Selling Price by Country, Total Cerebrospinal Fluid External Drainage System Market, Europe, 2019 – 2029 (€) |
| Figure 8‑28: Average Selling Price by Country, Total Cerebrospinal Fluid External Drainage System Market, Europe, 2019 – 2029 (US$) |
| Figure 8‑29: Market Value by Country, Total Cerebrospinal Fluid External Drainage System Market, Europe, 2019 – 2029 (€M) |
| Figure 8‑30: Market Value by Country, Total Cerebrospinal Fluid External Drainage System Market, Europe, 2019 – 2029 (US$M) |
| Figure 8‑31: Ventricular Drainage System Market, Europe, 2019 – 2029 |
| Figure 8‑32: Units Sold by Country, Ventricular Drainage System Market, Europe, 2019 – 2029 |
| Figure 8‑33: Average Selling Price by Country, Ventricular Drainage System Market, Europe, 2019 – 2029 (€) |
| Figure 8‑34: Average Selling Price by Country, Ventricular Drainage System Market, Europe, 2019 – 2029 (US$) |
| Figure 8‑35: Market Value by Country, Ventricular Drainage System Market, Europe, 2019 – 2029 (€M) |
| Figure 8‑36: Market Value by Country, Ventricular Drainage System Market, Europe, 2019 – 2029 (US$M) |
| Figure 8‑37: Lumbar Drainage System Market, Europe, 2019 – 2029 |
| Figure 8‑38: Units Sold by Country, Lumbar Drainage System Market, Europe, 2019 – 2029 |
| Figure 8‑39: Average Selling Price by Country, Lumbar Drainage System Market, Europe, 2019 – 2029 (€) |
| Figure 8‑40: Average Selling Price by Country, Lumbar Drainage System Market, Europe, 2019 – 2029 (US$) |
| Figure 8‑41: Market Value by Country, Lumbar Drainage System Market, Europe, 2019 – 2029 (€M) |
| Figure 8‑42: Market Value by Country, Lumbar Drainage System Market, Europe, 2019 – 2029 (US$M) |
| Figure 8‑43: Leading Competitors, Cerebrospinal Fluid Management Market, Europe, 2022 |
| Figure 8‑44: Leading Competitors, Cerebrospinal Fluid Shunt Market, Europe, 2022 |
| Figure 9‑1: Detachable Coil Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 9‑2: Detachable Coil Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 9‑3: Detachable Coil Market, Europe, 2019 – 2029 |
| Figure 9‑4: Units Sold by Country, Detachable Coil Market, Europe, 2019 – 2029 |
| Figure 9‑5: Average Selling Price by Country, Detachable Coil Market, Europe, 2019 – 2029 (€) |
| Figure 9‑6: Average Selling Price by Country, Detachable Coil Market, Europe, 2019 – 2029 (US$) |
| Figure 9‑7: Market Value by Country, Detachable Coil Market, Europe, 2019 – 2029 (€M) |
| Figure 9‑8: Market Value by Country, Detachable Coil Market, Europe, 2019 – 2029 (US$M) |
| Figure 9‑9: Bare Platinum Detachable Coil Market, Europe, 2019 – 2029 |
| Figure 9‑10: Units Sold by Country, Bare Platinum Detachable Coil Market, Europe, 2019 – 2029 |
| Figure 9‑11: Average Selling Price by Country, Bare Platinum Detachable Coil Market, Europe, 2019 – 2029 (€) |
| Figure 9‑12: Average Selling Price by Country, Bare Platinum Detachable Coil Market, Europe, 2019 – 2029 (US$) |
| Figure 9‑13: Market Value by Country, Bare Platinum Detachable Coil Market, Europe, 2019 – 2029 (€M) |
| Figure 9‑14: Market Value by Country, Bare Platinum Detachable Coil Market, Europe, 2019 – 2029 (US$M) |
| Figure 9‑15: Coated Detachable Coil Market, Europe, 2019 – 2029 |
| Figure 9‑16: Units Sold by Country, Coated Detachable Coil Market, Europe, 2019 – 2029 |
| Figure 9‑17: Average Selling Price by Country, Coated Detachable Coil Market, Europe, 2019 – 2029 (€) |
| Figure 9‑18: Average Selling Price by Country, Coated Detachable Coil Market, Europe, 2019 – 2029 (US$) |
| Figure 9‑19: Market Value by Country, Coated Detachable Coil Market, Europe, 2019 – 2029 (€M) |
| Figure 9‑20: Market Value by Country, Coated Detachable Coil Market, Europe, 2019 – 2029 (US$M) |
| Figure 9‑21: Leading Competitors, Detachable Coil Market, Europe, 2022 |
| Figure 10‑1: Liquid Embolic Market, Europe, 2019 – 2029 |
| Figure 10‑2: Units Sold by Country, Liquid Embolic Market, Europe, 2019 – 2029 |
| Figure 10‑3: Average Selling Price by Country, Liquid Embolic Market, Europe, 2019 – 2029 (€) |
| Figure 10‑4: Average Selling Price by Country, Liquid Embolic Market, Europe, 2019 – 2029 (US$) |
| Figure 10‑5: Market Value by Country, Liquid Embolic Market, Europe, 2019 – 2029 (€M) |
| Figure 10‑6: Market Value by Country, Liquid Embolic Market, Europe, 2019 – 2029 (US$M) |
| Figure 10‑7: Leading Competitors, Liquid Embolic Market, Europe, 2022 |
| Figure 11‑1: Neurovascular Guidewire Market, Europe, 2019 – 2029 |
| Figure 11‑2: Units Sold by Country, Neurovascular Guidewire Market, Europe, 2019 – 2029 |
| Figure 11‑3: Average Selling Price by Country, Neurovascular Guidewire Market, Europe, 2019 – 2029 (€) |
| Figure 11‑4: Average Selling Price by Country, Neurovascular Guidewire Market, Europe, 2019 – 2029 (US$) |
| Figure 11‑5: Market Value by Country, Neurovascular Guidewire Market, Europe, 2019 – 2029 (€M) |
| Figure 11‑6: Market Value by Country, Neurovascular Guidewire Market, Europe, 2019 – 2029 (US$M) |
| Figure 11‑7: Leading Competitors, Neurovascular Guidewire Market, Europe, 2022 |
| Figure 12‑1: Neurovascular Catheter Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 12‑2: Neurovascular Catheter Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 12‑3: Over-the-Wire Microcatheter Market, Europe, 2019 – 2029 |
| Figure 12‑4: Units Sold by Country, Over-the-Wire Microcatheter Market, Europe, 2019 – 2029 |
| Figure 12‑5: Average Selling Price by Country, Over-the-Wire Microcatheter Market, Europe, 2019 – 2029 (€) |
| Figure 12‑6: Average Selling Price by Country, Over-the-Wire Microcatheter Market, Europe, 2019 – 2029 (US$) |
| Figure 12‑7: Market Value by Country, Over-the-Wire Microcatheter Market, Europe, 2019 – 2029 (€M) |
| Figure 12‑8: Market Value by Country, Over-the-Wire Microcatheter Market, Europe, 2019 – 2029 (US$M) |
| Figure 12‑9: Flow-Directed Microcatheter Market, Europe, 2019 – 2029 |
| Figure 12‑10: Units Sold by Country, Flow-Directed Microcatheter Market, Europe, 2019 – 2029 |
| Figure 12‑11: Average Selling Price by Country, Flow-Directed Microcatheter Market, Europe, 2019 – 2029 (€) |
| Figure 12‑12: Average Selling Price by Country, Flow-Directed Microcatheter Market, Europe, 2019 – 2029 (US$) |
| Figure 12‑13: Market Value by Country, Flow-Directed Microcatheter Market, Europe, 2019 – 2029 (€M) |
| Figure 12‑14: Market Value by Country, Flow-Directed Microcatheter Market, Europe, 2019 – 2029 (US$M) |
| Figure 12‑15: Neurovascular Guiding Catheter Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 12‑16: Neurovascular Guiding Catheter Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 12‑17: Total Neurovascular Guiding Catheter Market, Europe, 2019 – 2029 |
| Figure 12‑18: Units Sold by Country, Total Neurovascular Guiding Catheter Market, Europe, 2019 – 2029 |
| Figure 12‑19: Average Selling Price by Country, Total Neurovascular Guiding Catheter Market, Europe, 2019 – 2029 (€) |
| Figure 12‑20: Average Selling Price by Country, Total Neurovascular Guiding Catheter Market, Europe, 2019 – 2029 (US$) |
| Figure 12‑21: Market Value by Country, Total Neurovascular Guiding Catheter Market, Europe, 2019 – 2029 (€M) |
| Figure 12‑22: Market Value by Country, Total Neurovascular Guiding Catheter Market, Europe, 2019 – 2029 (US$M) |
| Figure 12‑23: Standard Guiding Catheter Market, Europe, 2019 – 2029 |
| Figure 12‑24: Units Sold by Country, Standard Guiding Catheter Market, Europe, 2019 – 2029 |
| Figure 12‑25: Average Selling Price by Country, Standard Guiding Catheter Market, Europe, 2019 – 2029 (€) |
| Figure 12‑26: Average Selling Price by Country, Standard Guiding Catheter Market, Europe, 2019 – 2029 (US$) |
| Figure 12‑27: Market Value by Country, Standard Guiding Catheter Market, Europe, 2019 – 2029 (€M) |
| Figure 12‑28: Market Value by Country, Standard Guiding Catheter Market, Europe, 2019 – 2029 (US$M) |
| Figure 12‑29: Balloon Guiding Catheter Market, Europe, 2019 – 2029 |
| Figure 12‑30: Units Sold by Country, Balloon Guiding Catheter Market, Europe, 2019 – 2029 |
| Figure 12‑31: Average Selling Price by Country, Balloon Guiding Catheter Market, Europe, 2019 – 2029 (€) |
| Figure 12‑32: Average Selling Price by Country, Balloon Guiding Catheter Market, Europe, 2019 – 2029 (US$) |
| Figure 12‑33: Market Value by Country, Balloon Guiding Catheter Market, Europe, 2019 – 2029 (€M) |
| Figure 12‑34: Market Value by Country, Balloon Guiding Catheter Market, Europe, 2019 – 2029 (US$M) |
| Figure 12‑35: Leading Competitors, Neurovascular Catheter Market, Europe, 2022 |
| Figure 13‑1: Neurovascular Stent Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 13‑2: Neurovascular Stent Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 13‑3: Traditional Neurovascular Stent Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 13‑4: Traditional Neurovascular Stent Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 13‑5: Total Traditional Neurovascular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑6: Units Sold by Country, Total Traditional Neurovascular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑7: Average Selling Price by Country, Total Traditional Neurovascular Stent Market, Europe, 2019 – 2029 (€) |
| Figure 13‑8: Average Selling Price by Country, Total Traditional Neurovascular Stent Market, Europe, 2019 – 2029 (US$) |
| Figure 13‑9: Market Value by Country, Total Traditional Neurovascular Stent Market, Europe, 2019 – 2029 (€M) |
| Figure 13‑10: Market Value by Country, Total Traditional Neurovascular Stent Market, Europe, 2019 – 2029 (US$M) |
| Figure 13‑11: Laser Cut Neurovascular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑12: Units Sold by Country, Laser Cut Neurovascular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑13: Average Selling Price by Country, Laser Cut Neurovascular Stent Market, Europe, 2019 – 2029 (€) |
| Figure 13‑14: Average Selling Price by Country, Laser Cut Neurovascular Stent Market, Europe, 2019 – 2029 (US$) |
| Figure 13‑15: Market Value by Country, Laser Cut Neurovascular Stent Market, Europe, 2019 – 2029 (€M) |
| Figure 13‑16: Market Value by Country, Laser Cut Neurovascular Stent Market, Europe, 2019 – 2029 (US$M) |
| Figure 13‑17: Braided Neurovascular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑18: Units Sold by Country, Braided Neurovascular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑19: Average Selling Price by Country, Braided Neurovascular Stent Market, Europe, 2019 – 2029 (€) |
| Figure 13‑20: Average Selling Price by Country, Braided Neurovascular Stent Market, Europe, 2019 – 2029 (US$) |
| Figure 13‑21: Market Value by Country, Braided Neurovascular Stent Market, Europe, 2019 – 2029 (€M) |
| Figure 13‑22: Market Value by Country, Braided Neurovascular Stent Market, Europe, 2019 – 2029 (US$M) |
| Figure 13‑23: Flow Diversion Stent Market, Europe, 2019 – 2029 |
| Figure 13‑24: Units Sold by Country, Flow Diversion Stent Market, Europe, 2019 – 2029 |
| Figure 13‑25: Average Selling Price by Country, Flow Diversion Stent Market, Europe, 2019 – 2029 (€) |
| Figure 13‑26: Average Selling Price by Country, Flow Diversion Stent Market, Europe, 2019 – 2029 (US$) |
| Figure 13‑27: Market Value by Country, Flow Diversion Stent Market, Europe, 2019 – 2029 (€M) |
| Figure 13‑28: Market Value by Country, Flow Diversion Stent Market, Europe, 2019 – 2029 (US$M) |
| Figure 13‑29: Intrasaccular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑30: Units Sold by Country, Intrasaccular Stent Market, Europe, 2019 – 2029 |
| Figure 13‑31: Average Selling Price by Country, Intrasaccular Stent Market, Europe, 2019 – 2029 (€) |
| Figure 13‑32: Average Selling Price by Country, Intrasaccular Stent Market, Europe, 2019 – 2029 (US$) |
| Figure 13‑33: Market Value by Country, Intrasaccular Stent Market, Europe, 2019 – 2029 (€M) |
| Figure 13‑34: Market Value by Country, Intrasaccular Stent Market, Europe, 2019 – 2029 (US$M) |
| Figure 13‑35: Leading Competitors, Neurovascular Stent Market, Europe, 2022 |
| Figure 14‑1: Aneurysm Clip Market by Material, Europe, 2019 – 2029 (€M) |
| Figure 14‑2: Aneurysm Clip Market by Material, Europe, 2019 – 2029 (US$M) |
| Figure 14‑3: Aneurysm Clip Market, Europe, 2019 – 2029 |
| Figure 14‑4: Units Sold by Country, Aneurysm Clip Market, Europe, 2019 – 2029 |
| Figure 14‑5: Average Selling Price by Country, Aneurysm Clip Market, Europe, 2019 – 2029 (€) |
| Figure 14‑6: Average Selling Price by Country, Aneurysm Clip Market, Europe, 2019 – 2029 (US$) |
| Figure 14‑7: Market Value by Country, Aneurysm Clip Market, Europe, 2019 – 2029 (€M) |
| Figure 14‑8: Market Value by Country, Aneurysm Clip Market, Europe, 2019 – 2029 (US$M) |
| Figure 14‑9: Titanium Aneurysm Clip Market, Europe, 2019 – 2029 |
| Figure 14‑10: Units Sold by Country, Titanium Aneurysm Clip Market, Europe, 2019 – 2029 |
| Figure 14‑11: Average Selling Price by Country, Titanium Aneurysm Clip Market, Europe, 2019 – 2029 (€) |
| Figure 14‑12: Average Selling Price by Country, Titanium Aneurysm Clip Market, Europe, 2019 – 2029 (US$) |
| Figure 14‑13: Market Value by Country, Titanium Aneurysm Clip Market, Europe, 2019 – 2029 (€M) |
| Figure 14‑14: Market Value by Country, Titanium Aneurysm Clip Market, Europe, 2019 – 2029 (US$M) |
| Figure 14‑15: Cobalt Chromium Aneurysm Clip Market, Europe, 2019 – 2029 |
| Figure 14‑16: Units Sold by Country, Cobalt Chromium Aneurysm Clip Market, Europe, 2019 – 2029 |
| Figure 14‑17: Average Selling Price by Country, Cobalt Chromium Aneurysm Clip Market, Europe, 2019 – 2029 (€) |
| Figure 14‑18: Average Selling Price by Country, Cobalt Chromium Aneurysm Clip Market, Europe, 2019 – 2029 (US$) |
| Figure 14‑19: Market Value by Country, Cobalt Chromium Aneurysm Clip Market, Europe, 2019 – 2029 (€M) |
| Figure 14‑20: Market Value by Country, Cobalt Chromium Aneurysm Clip Market, Europe, 2019 – 2029 (US$M) |
| Figure 14‑21: Leading Competitors, Aneurysm Clip Market, Europe, 2022 |
| Figure 15‑1: Balloon Occlusion Device Market, Europe, 2019 – 2029 |
| Figure 15‑2: Units Sold by Country, Balloon Occlusion Device Market, Europe, 2019 – 2029 |
| Figure 15‑3: Average Selling Price by Country, Balloon Occlusion Device Market, Europe, 2019 – 2029 (€) |
| Figure 15‑4: Average Selling Price by Country, Balloon Occlusion Device Market, Europe, 2019 – 2029 (US$) |
| Figure 15‑5: Market Value by Country, Balloon Occlusion Device Market, Europe, 2019 – 2029 (€M) |
| Figure 15‑6: Market Value by Country, Balloon Occlusion Device Market, Europe, 2019 – 2029 (US$M) |
| Figure 15‑7: Leading Competitors, Balloon Occlusion Device Market, Europe, 2022 |
| Figure 16‑1: Neurovascular Thrombectomy Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 16‑2: Neurovascular Thrombectomy Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 16‑3: Stent Retriever Market, Europe, 2019 – 2029 |
| Figure 16‑4: Units Sold by Country, Stent Retriever Market, Europe, 2019 – 2029 |
| Figure 16‑5: Average Selling Price by Country, Stent Retriever Market, Europe, 2019 – 2029 (€) |
| Figure 16‑6: Average Selling Price by Country, Stent Retriever Market, Europe, 2019 – 2029 (US$) |
| Figure 16‑7: Market Value by Country, Stent Retriever Market, Europe, 2019 – 2029 (€M) |
| Figure 16‑8: Market Value by Country, Stent Retriever Market, Europe, 2019 – 2029 (US$M) |
| Figure 16‑9: Aspiration Catheter Market, Europe, 2019 – 2029 |
| Figure 16‑10: Units Sold by Country, Aspiration Catheter Market, Europe, 2019 – 2029 |
| Figure 16‑11: Average Selling Price by Country, Aspiration Catheter Market, Europe, 2019 – 2029 (€) |
| Figure 16‑12: Average Selling Price by Country, Aspiration Catheter Market, Europe, 2019 – 2029 (US$) |
| Figure 16‑13: Market Value by Country, Aspiration Catheter Market, Europe, 2019 – 2029 (€M) |
| Figure 16‑14: Market Value by Country, Aspiration Catheter Market, Europe, 2019 – 2029 (US$M) |
| Figure 16‑15: Leading Competitors, Neurovascular Thrombectomy Market, Europe, 2022 |
| Figure 17‑1: Ultrasonic Aspirator Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 17‑2: Ultrasonic Aspirator Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 17‑3: Ultrasonic Aspirator Generator Market, Europe, 2019 – 2029 |
| Figure 17‑4: Units Sold by Country, Ultrasonic Aspirator Generator Market, Europe, 2019 – 2029 |
| Figure 17‑5: Average Selling Price by Country, Ultrasonic Aspirator Generator Market, Europe, 2019 – 2029 (€) |
| Figure 17‑6: Average Selling Price by Country, Ultrasonic Aspirator Generator Market, Europe, 2019 – 2029 (US$) |
| Figure 17‑7: Market Value by Country, Ultrasonic Aspirator Generator Market, Europe, 2019 – 2029 (€M) |
| Figure 17‑8: Market Value by Country, Ultrasonic Aspirator Generator Market, Europe, 2019 – 2029 (US$M) |
| Figure 17‑9: Ultrasonic Aspirator Disposable Probe Tip Market, Europe, 2019 – 2029 |
| Figure 17‑10: Units Sold by Country, Ultrasonic Aspirator Disposable Probe Tip Market, Europe, 2019 – 2029 |
| Figure 17‑11: Average Selling Price by Country, Ultrasonic Aspirator Disposable Probe Tip Market, Europe, 2019 – 2029 (€) |
| Figure 17‑12: Average Selling Price by Country, Ultrasonic Aspirator Disposable Probe Tip Market, Europe, 2019 – 2029 (US$) |
| Figure 17‑13: Market Value by Country, Ultrasonic Aspirator Disposable Probe Tip Market, Europe, 2019 – 2029 (€M) |
| Figure 17‑14: Market Value by Country, Ultrasonic Aspirator Disposable Probe Tip Market, Europe, 2019 – 2029 (US$M) |
| Figure 17‑15: Ultrasonic Aspirator Disposable Tubing Market, Europe, 2019 – 2029 |
| Figure 17‑16: Units Sold by Country, Ultrasonic Aspirator Disposable Tubing Market, Europe, 2019 – 2029 |
| Figure 17‑17: Average Selling Price by Country, Ultrasonic Aspirator Disposable Tubing Market, Europe, 2019 – 2029 (€) |
| Figure 17‑18: Average Selling Price by Country, Ultrasonic Aspirator Disposable Tubing Market, Europe, 2019 – 2029 (US$) |
| Figure 17‑19: Market Value by Country, Ultrasonic Aspirator Disposable Tubing Market, Europe, 2019 – 2029 (€M) |
| Figure 17‑20: Market Value by Country, Ultrasonic Aspirator Disposable Tubing Market, Europe, 2019 – 2029 (US$M) |
| Figure 17‑21: Leading Competitors, Ultrasonic Aspirator Market, Europe, 2022 |
| Figure 18‑1: Neuromodulation Device Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 18‑2: Neuromodulation Device Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 18‑3: Spinal Cord Stimulator Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 18‑4: Spinal Cord Stimulator Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 18‑5: Total Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑6: Units Sold by Country, Total Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑7: Average Selling Price by Country, Total Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑8: Average Selling Price by Country, Total Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑9: Market Value by Country, Total Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑10: Market Value by Country, Total Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑11: Spinal Cord Stimulator Generator Market by Battery Type, Europe, 2019 – 2029 (€M) |
| Figure 18‑12: Spinal Cord Stimulator Generator Market by Battery Type, Europe, 2019 – 2029 (US$M) |
| Figure 18‑13: Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑14: Units Sold by Country, Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑15: Average Selling Price by Country, Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑16: Average Selling Price by Country, Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑17: Market Value by Country, Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑18: Market Value by Country, Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑19: Non-Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑20: Units Sold by Country, Non-Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑21: Average Selling Price by Country, Non-Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑22: Average Selling Price by Country, Non-Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑23: Market Value by Country, Non-Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑24: Market Value by Country, Non-Rechargeable Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑25: Spinal Cord Stimulator Generator Market by Channel Type, Europe, 2019 – 2029 (€M) |
| Figure 18‑26: Spinal Cord Stimulator Generator Market by Channel Type, Europe, 2019 – 2029 (US$M) |
| Figure 18‑27: Single-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑28: Units Sold by Country, Single-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑29: Average Selling Price by Country, Single-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑30: Average Selling Price by Country, Single-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑31: Market Value by Country, Single-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑32: Market Value by Country, Single-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑33: Multi-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑34: Units Sold by Country, Multi-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 |
| Figure 18‑35: Average Selling Price by Country, Multi-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑36: Average Selling Price by Country, Multi-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑37: Market Value by Country, Multi-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑38: Market Value by Country, Multi-Channel Spinal Cord Stimulator Generator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑39: Spinal Cord Stimulator Lead Market, Europe, 2019 – 2029 |
| Figure 18‑40: Units Sold by Country, Spinal Cord Stimulator Lead Market, Europe, 2019 – 2029 |
| Figure 18‑41: Average Selling Price by Country, Spinal Cord Stimulator Lead Market, Europe, 2019 – 2029 (€) |
| Figure 18‑42: Average Selling Price by Country, Spinal Cord Stimulator Lead Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑43: Market Value by Country, Spinal Cord Stimulator Lead Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑44: Market Value by Country, Spinal Cord Stimulator Lead Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑45: Deep Brain Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑46: Units Sold by Country, Deep Brain Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑47: Average Selling Price by Country, Deep Brain Stimulator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑48: Average Selling Price by Country, Deep Brain Stimulator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑49: Market Value by Country, Deep Brain Stimulator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑50: Market Value by Country, Deep Brain Stimulator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑51: Sacral Nerve Stimulator Market by Battery Type, Europe, 2019 – 2029 (€M) |
| Figure 18‑52: Sacral Nerve Stimulator Market by Battery Type, Europe, 2019 – 2029 (US$M) |
| Figure 18‑53: Total Sacral Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑54: Units Sold by Country, Total Sacral Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑55: Average Selling Price by Country, Total Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑56: Average Selling Price by Country, Total Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑57: Market Value by Country, Total Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑58: Market Value by Country, Total Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑59: Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑60: Units Sold by Country, Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑61: Average Selling Price by Country, Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑62: Average Selling Price by Country, Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑63: Market Value by Country, Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑64: Market Value by Country, Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑65: Non-Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑66: Units Sold by Country, Non-Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑67: Average Selling Price by Country, Non-Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑68: Average Selling Price by Country, Non-Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑69: Market Value by Country, Non-Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑70: Market Value by Country, Non-Rechargeable Sacral Nerve Stimulator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑71: Vagus Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑72: Units Sold by Country, Vagus Nerve Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑73: Average Selling Price by Country, Vagus Nerve Stimulator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑74: Average Selling Price by Country, Vagus Nerve Stimulator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑75: Market Value by Country, Vagus Nerve Stimulator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑76: Market Value by Country, Vagus Nerve Stimulator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑77: Gastric Electric Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑78: Units Sold by Country, Gastric Electric Stimulator Market, Europe, 2019 – 2029 |
| Figure 18‑79: Average Selling Price by Country, Gastric Electric Stimulator Market, Europe, 2019 – 2029 (€) |
| Figure 18‑80: Average Selling Price by Country, Gastric Electric Stimulator Market, Europe, 2019 – 2029 (US$) |
| Figure 18‑81: Market Value by Country, Gastric Electric Stimulator Market, Europe, 2019 – 2029 (€M) |
| Figure 18‑82: Market Value by Country, Gastric Electric Stimulator Market, Europe, 2019 – 2029 (US$M) |
| Figure 18‑83: Leading Competitors, Neuromodulation Device Market, Europe, 2022 |
| Figure 19‑1: Intrathecal Pump Market, Europe, 2019 – 2029 |
| Figure 19‑2: Units Sold by Country, Intrathecal Pump Market, Europe, 2019 – 2029 |
| Figure 19‑3: Average Selling Price by Country, Intrathecal Pump Market, Europe, 2019 – 2029 (€) |
| Figure 19‑4: Average Selling Price by Country, Intrathecal Pump Market, Europe, 2019 – 2029 (US$) |
| Figure 19‑5: Market Value by Country, Intrathecal Pump Market, Europe, 2019 – 2029 (€M) |
| Figure 19‑6: Market Value by Country, Intrathecal Pump Market, Europe, 2019 – 2029 (US$M) |
| Figure 19‑7: Leading Competitors, Intrathecal Pump Market, Europe, 2022 |
| Figure 20‑1: Stereotactic Device Market by Segment, Europe, 2019 – 2029 (€M) |
| Figure 20‑2: Stereotactic Device Market by Segment, Europe, 2019 – 2029 (US$M) |
| Figure 20‑3: Frame-Based Stereotactic Device Market, Europe, 2019 – 2029 |
| Figure 20‑4: Units Sold by Country, Frame-Based Stereotactic Device Market, Europe, 2019 – 2029 |
| Figure 20‑5: Average Selling Price by Country, Frame-Based Stereotactic Device Market, Europe, 2019 – 2029 (€) |
| Figure 20‑6: Average Selling Price by Country, Frame-Based Stereotactic Device Market, Europe, 2019 – 2029 (US$) |
| Figure 20‑7: Market Value by Country, Frame-Based Stereotactic Device Market, Europe, 2019 – 2029 (€M) |
| Figure 20‑8: Market Value by Country, Frame-Based Stereotactic Device Market, Europe, 2019 – 2029 (US$M) |
| Figure 20‑9: Frameless Stereotactic Device Market, Europe, 2019 – 2029 |
| Figure 20‑10: Units Sold by Country, Frameless Stereotactic Device Market, Europe, 2019 – 2029 |
| Figure 20‑11: Average Selling Price by Country, Frameless Stereotactic Device Market, Europe, 2019 – 2029 (€) |
| Figure 20‑12: Average Selling Price by Country, Frameless Stereotactic Device Market, Europe, 2019 – 2029 (US$) |
| Figure 20‑13: Market Value by Country, Frameless Stereotactic Device Market, Europe, 2019 – 2029 (€M) |
| Figure 20‑14: Market Value by Country, Frameless Stereotactic Device Market, Europe, 2019 – 2029 (US$M) |
| Figure 20‑15: Leading Competitors, Stereotactic Device Market, Europe, 2022 |
| Figure 20‑16: Leading Competitors by Country, Stereotactic Device Market, Europe, 2022 |
| Figure 20‑17: Leading Competitors by Country, Frame-Based Stereotactic Device Market, Europe, 2022 |
| Figure 20‑18: Leading Competitors by Country, Frameless Stereotactic Device Market, Europe, 2022 |
| Figure 21‑1: Transcranial Magnetic Stimulator Market, Europe, 2019 – 2029 |
| Figure 21‑2: Leading Competitors, Transcranial Magnetic Stimulator Market, Europe, 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Neurological Devices Market Size, Share & COVID-19 Analysis | Europe | 2023-2029 | MedSuite | Includes: Ultrasonic Aspirator Market, Neurovascular Guidewires Market, and 12 more
$8,995 – $10,995
The full report suite on the European market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, balloon occlusion devices, neurovascular thrombectomy devices, ultrasonic aspirators, neuromodulation devices, intrathecal pumps, stereotactic devices and transcranial magnetic simulators.
- 2023
- 10 Years
- Europe
- 11/21/2022
- 692
- MedSuite
Related Reports
